SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Eva Perón — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEva Perón
Date of birth1919-05-07
IdentifiersMRN HR-ML025-SYN-TD; SSN (made up) 000-25-7316
Document date1951-08-17
AuthorLucía Barragán, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Review three months after treatment, with the PET-CT result. [S]

History of Present Illness

Ms. Perón returns three and a half months after finishing treatment. Her PET-CT a week ago showed a complete metabolic response, with no uptake in the cervix, nodes or elsewhere, and Dr. Osei-Bonsu's examination last month found no tumor. The estradiol patch and progesterone stopped the hot flashes and night sweats within a few weeks. She uses the dilator three times a week; intercourse is comfortable with a lubricant. Her energy is nearly back, she has regained weight, and she is working full days again. She has had no bleeding, pelvic or back pain, or leg swelling. [S]

ElementDetail
PET-CTComplete metabolic response a week ago
Menopause careSymptoms controlled on estradiol and progesterone
DilatorThree times a week
WorkFull days again
ScoresPHQ-9 4; GAD-7 4; pain 0

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy nearly normal; weight regained; no night sweats
GastrointestinalNegativeBowels normal; no rectal bleeding
GenitourinaryNegativeNo bleeding or discharge; no urinary symptoms
MusculoskeletalNegativeNo back or pelvic pain; no leg swelling
PsychiatricNegativeMood good; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairyOne tablet by mouth once dailyOral route1951-02-09 to 1951-08-17completedS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a dayOne or two tablets every 6 hours when needed, no more than 6 a dayOral route1951-02-09activeS
Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 daysOne capsule twice daily with food for 5 daysOral route1951-03-27 to 1951-03-31completedS
Cisplatin 40 mg/m2 (64 mg) intravenous infusion once weekly for five weeks during pelvic radiation, with hydration and antiemetic premedication in the infusion center64 mg intravenously once weekly for five dosesIntravenous route1951-03-09 to 1951-04-06completedS
Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours when needed for nausea in the days after cisplatinOne tablet every 8 hours when needed for nauseaOral route1951-03-09 to 1951-04-10completedS
Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than 8 a dayTwo capsules after the first loose stool, then one after each, no more than 8 a dayOral route1951-03-09 to 1951-05-04completedS
Estradiol 0.1 mg per day transdermal patch, one patch changed twice weeklyOne patch changed twice weeklyTopical route1951-05-18activeS
Progesterone 100 mg oral capsule, one capsule by mouth nightly, to protect any remaining endometrium while on estradiolOne capsule by mouth nightlyOral route1951-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1951-08-17Body height165cmS
1951-08-17Body weight52.4kgS
1951-08-17Body mass index (BMI) [Ratio]19.2kg/m2S
1951-08-17Systolic blood pressure108mm[Hg]S
1951-08-17Diastolic blood pressure68mm[Hg]S
1951-08-17Heart rate74/minS
1951-08-17Respiratory rate14/minS
1951-08-17Body temperature36.6CelS
1951-08-17Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1951-08-17Hemoglobin [Mass/volume] in Blood12.6g/dL11.6-15 g/dLNormalS
1951-08-17Ferritin [Mass/volume] in Serum or Plasma48ng/mLA ferritin of 30 ng/mL or less indicates iron deficiencyNormalS
1951-08-17Pain severity - 0-10 verbal numeric rating [Score] - Reported0{score}S
1951-08-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1951-08-17Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S

Physical Exam

Vital signs recorded on 1951-08-17; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 52.4 kg; blood pressure 108/68
Lymph nodesNo inguinal or supraclavicular nodes
PelvicCervix small, pale and smooth, with radiation changes and no mass; upper vagina mildly narrowed; rectovaginal examination: parametria soft, without nodularity
LegsNo swelling

Problems

ProblemClinical statusVerificationCodeProvenance
Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation bookedresolvedconfirmed N93.8S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation.
Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairsresolvedconfirmed D50.0S — Synthetic modern finding linked to her documented anemia from vaginal bleeding.
Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 1943 staging. Synthetic modern episode linked to her documented cervical canceractiveconfirmed C53.9S — Synthetic modern diagnosis made at the gynecologic oncology consultation.
Acute cystitis during pelvic chemoradiation: two days of new burning, urgency and cloudy urine on top of mild radiation frequency, without fever or flank pain; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; neutrophil count and kidney function normal; resolvedresolvedconfirmed N30.00S — Synthetic acute infection; not a historical claim.
Ovarian failure after pelvic radiation, with hot flashes, night sweats, poor sleep and vaginal dryness two weeks after treatment; FSH 72 mIU/mL and estradiol 14 pg/mLactiveconfirmed E89.41S — Synthetic expected effect of pelvic chemoradiation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ImagingFDG PET-CTAt staging; about three months after chemoradiationUp to dateA week ago: complete metabolic response
ExaminationPelvic, speculum and rectovaginal examinationAt diagnosis; every three to six months for two years after treatmentCompleted todayNo tumor; parametria soft; upper vagina mildly narrowed
LaboratoryBlood count (hemoglobin, white cells, platelets)About one month after starting oral iron, then every three months for a year; weekly during chemoradiationCompleted todayHemoglobin 12.6 g/dL
LaboratoryFerritinAt the end of the iron courseCompleted today48 ng/mL; iron stopped
ExaminationTreatment side effects (bowel, bladder, skin, nausea, hearing, nerve symptoms)At each visitCompleted todayNo late bowel or bladder effects; no hearing loss or neuropathy
SurveyPelvic pain score and analgesic safety (no anti-inflammatory painkillers with cisplatin)Every visitCompleted today0 of 10
SurveyPHQ-9 and GAD-7At diagnosis, before treatment, at mid-treatment, at the end of treatment, and in follow-upCompleted todayPHQ-9 4 (item 9 scored 0), GAD-7 4
Self-managementVaginal dilator useStarting two to four weeks after radiation, three times a weekCompleted todayThree times a week; intercourse comfortable
Medication safetyHormone therapy safety (blood pressure, clot symptoms) and symptom controlAt the start and every visitCompleted todayBlood pressure 108/68; no clot symptoms; symptoms controlled
ReferralSurvivorship care plan and gynecologic oncology follow-upFrom the end of treatmentCompleted todayWritten plan in Spanish given; gynecologic oncology next month
ReferralOncology social worker and spiritual careThrough treatment and survivorshipCompleted todayMonthly social work visits

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017); Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)

Follow-up: Gynecologic oncology review next month. Preventive visit in about a month. Next scheduled visit 1951-09-21: periodic adult preventive visit after cancer treatment. [S]